Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3 (BioSput-Air)

This study has been terminated.
(A lot of patients recruited in our center were already on montelukast treatment. It was not possible to recruit sufficient patients for the study.)
Information provided by (Responsible Party):
Dominque Bullens, Universitaire Ziekenhuizen Leuven Identifier:
First received: October 18, 2010
Last updated: October 22, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)